Reddy, Anita
Winther, Sally http://orcid.org/0000-0003-4566-5228
Tran, Nhien http://orcid.org/0000-0002-5009-9323
Xiao, Haopeng http://orcid.org/0000-0002-4166-647X
Jakob, Josefine
Garrity, Ryan
Smith, Arianne
Ordonez, Martha
Laznik-Bogoslavski, Dina
Rothstein, Jeffrey D.
Mills, Evanna L. http://orcid.org/0000-0003-0447-8995
Chouchani, Edward T. http://orcid.org/0000-0002-9776-8790
Funding for this research was provided by:
Foundation for the National Institutes of Health (DK123095)
Article History
Received: 2 April 2023
Accepted: 9 January 2024
First Online: 20 February 2024
Competing interests
: E.T.C. is scientific founder and equity holder in Matchpoint Therapeutics and Aevum Therapeutics. All other authors declare no competing interests.